Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Abstract The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the…
Abstract The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the…
Abstract Background: For patients with chronic, non-cancer pain, traditional pain-relieving medications include opioids, which have shown benefits but are associated…
Abstract Dysfunctions in the endocannabinoid system have been associated with experimental animal models and multiple sclerosis patients. Interestingly, the endocannabinoid…
Abstract Objective: The objective of this study was to characterize the use of cannabis-based products (CBPs) by multiple sclerosis (MS)…
Abstract Multiple sclerosis (MS) is a chronic and disabling disorder of the central nervous system (CNS) characterized by neuroinflammation leading…
Abstract NK cells (natural killer cells) being a part of the innate immune system have been shown to be involved…
Abstract Glia form a central component of the nervous system whose varied activities sustain an environment that is optimised for…
Abstract Background/purpose: Spasticity is one of the most common symptoms in people with multiple sclerosis (MS). Conventional anti-spasticity agents have…
Abstract The mammalian target of rapamycin (mTOR) has a fundamental role in the metabolism, growth, and regulation of the immune…
Abstract Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervous system…